Additionally, the 36-month beta value for TFFP is 1.23. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for TFFP is 3.10M and currently, short sellers hold a 5.55% ratio of that float. The average trading volume of TFFP on November 15, 2024 was 72.91K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
TFFP) stock’s latest price update
Tff Pharmaceuticals Inc (NASDAQ: TFFP) has seen a decline in its stock price by -4.76 in relation to its previous close of 1.68. However, the company has experienced a -1.84% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-14 that FORT WORTH, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special meeting of the board of directors.
TFFP’s Market Performance
Tff Pharmaceuticals Inc (TFFP) has seen a -1.84% fall in stock performance for the week, with a -23.44% decline in the past month and a -21.57% plunge in the past quarter. The volatility ratio for the week is 11.00%, and the volatility levels for the past 30 days are at 15.78% for TFFP. The simple moving average for the last 20 days is -21.15% for TFFP stock, with a simple moving average of -49.95% for the last 200 days.
Analysts’ Opinion of TFFP
Many brokerage firms have already submitted their reports for TFFP stocks, with H.C. Wainwright repeating the rating for TFFP by listing it as a “Buy.” The predicted price for TFFP in the upcoming period, according to H.C. Wainwright is $22 based on the research report published on May 19, 2022 of the previous year 2022.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see TFFP reach a price target of $31. The rating they have provided for TFFP stocks is “Buy” according to the report published on February 08th, 2021.
B. Riley Securities gave a rating of “Buy” to TFFP, setting the target price at $36 in the report published on December 07th of the previous year.
TFFP Trading at -21.84% from the 50-Day Moving Average
After a stumble in the market that brought TFFP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.45% of loss for the given period.
Volatility was left at 15.78%, however, over the last 30 days, the volatility rate increased by 11.00%, as shares sank -22.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.37% lower at present.
During the last 5 trading sessions, TFFP fell by -1.84%, which changed the moving average for the period of 200-days by -70.40% in comparison to the 20-day moving average, which settled at $2.0292. In addition, Tff Pharmaceuticals Inc saw -77.21% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TFFP
Current profitability levels for the company are sitting at:
- -12.51 for the present operating margin
- 0.66 for the gross margin
The net margin for Tff Pharmaceuticals Inc stands at -12.21. The total capital return value is set at -3.38. Equity return is now at value -213.51, with -168.10 for asset returns.
Based on Tff Pharmaceuticals Inc (TFFP), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -183.64. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -125.5.
Currently, EBITDA for the company is -20.74 million with net debt to EBITDA at 0.23. When we switch over and look at the enterprise to sales, we see a ratio of 0.78. The receivables turnover for the company is 3.96for trailing twelve months and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In conclusion, Tff Pharmaceuticals Inc (TFFP) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
